Key Takeaways The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, as the Federal Reserve announced its first interest-rate ...
The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Selling plaque psoriasis drug Vtama to Organon looks like another win for Roivant, which has been buying overlooked drugs, ...
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the ...
Senators Dick Durbin of Illinois and Mike Braun of Indiana recently introduced bipartisan legislation aimed at closing ...
Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments ...
But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness ...
On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 ...
On August 6, 2024, the Food and Drug Administration (FDA) partnered with the Clinical Trials Transformation Initiative ...
On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and ...